[Business Wire] – PASADENA, Calif.–(BUSINESSWIRE)– Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, today announced that academic collaborators and scientists from the company will present … moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click here to view […]
[at noodls] – PASADENA, Calif. – January 25, 2013 – Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it has priced a public offering of approximately 1.65 million units at a price to the public of … moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click […]
[at noodls] – PASADENA, Calif. – January 24, 2013 – Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it intends to offer units consisting of shares of common stock and warrants in a public offering. … moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click here […]
[at noodls] – PASADENA, Calif. – December 20, 2012 – Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, today announced financial results for its fiscal 2012 fourth quarter and year ended … moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click here to view […]
[at noodls] – PASADENA, Calif. – December 18, 2012 – Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, today announced that it has signed a research collaboration and license agreement … moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click here to view […]
[at noodls] – About Arrowhead Research Corporation Arrowhead Research Corporation is a clinical stage targeted therapeutics company with development programs in oncology, obesity, and chronic hepatitis B infection. … moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click here to view […]
[at noodls] – PASADENA, Calif. – December 7, 2012 – Arrowhead Research Corporation (NASDAQ: ARWR) today announced that it has priced a public offering of approximately 1.8 million units at a price to the public of $2.26 … moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, […]
[at noodls] – PASADENA, Calif. – December 6, 2012 – Arrowhead Research Corporation (NASDAQ: ARWR today announced that it intends to offer units consisting of shares of common stock and warrants in a public offering. … moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboardSee who Arrowhead is hiring next, click here […]
[at noodls] – PASADENA, Calif. – November 27, 2012 – Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, today announced the publication of data demonstrating that high level target gene … moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboard […]
[at noodls] – PASADENA, Calif. – November 13, 2012 – Arrowhead Research Corporation (NASDAQ: ARWR), a targeted therapeutics company, announced today that prominent hepatologist Robert G. Gish, MD, will serve as Chairman … moreView todays social media effects on ARWRView the latest stocks trending across Twitter. Click to view dashboard […]
